Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology Group
To access this article, please choose from the options below
PII: S0145-2126(03)00414-4
doi:10.1016/j.leukres.2003.12.002
© 2004 Published by Elsevier Inc.
